EMCDDA initial report on the new psychoactive substance 4F-MDMB-BICA
EMCDDA, Lisbon, November 2020 Summary Methyl 2-({[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}amino)-3,3-dimethylbutanoate (4FMDMB-BICA) is a synthetic cannabinoid receptor agonist. Similar to other synthetic cannabinoids, it is sold as a ‘legal’ re… read more

